Early hemodynamic response to angiotensin II defines a prognostic phenotype in bloodstream infection-associated septic shock
- Journal
- Journal of critical care (Q1)
- Published
- 13 August 2026
- Study design
- Retrospective cohort
- Evidence level
- Level 3, Low (CEBM 3b)
- Authors
- Georges Khattar, Kealy Ham, Shiloh Danley, Rodrigo Cartin-Ceba, Aaron Skolnik, Ayan Sen, et al.
- PMID
- 42594819
- DOI
- 10.1016/j.jcrc.2026.155708
Why clinicians should know about it
- Picked for Critical Care and Intensive Care Medicine (paper of the day, 15 August 2026): Early angiotensin II response predicts septic shock survival
Abstract
BACKGROUND: Angiotensin II is increasingly used as an adjunctive vasopressor in septic shock, but the clinical significance and determinants of early hemodynamic response remain incompletely understood. METHODS: We performed a retrospective cohort study of adults with bloodstream infection-associated septic shock treated with angiotensin II between 2019 and 2025. Early hemodynamic response was quantified as the proportional reduction in background norepinephrine-equivalent dose (NED) 3 h after angiotensin II initiation and analyzed as a continuous variable. The primary outcome was 30-day mortality. Multivariable logistic regression and 3-h landmark Cox proportional hazards models were used to evaluate associations between response magnitude and mortality. RESULTS: A total of 320 patients met inclusion criteria, of whom 207 (64.7%) were male and the mean age was 63.7 years (SD 14.7). Greater proportional reductions in NED at 3 h were independently associated with lower 30-day mortality (adjusted OR per 10% reduction, 0.83; 95% CI 0.76-0.90; p < 0.001), with similar findings in 3-h landmark Cox modeling (adjusted HR per 10% reduction, 0.89; 95% CI 0.85-0.92; p < 0.001). Findings were consistent when response was modeled using absolute reductions in NED and when angiotensin II was incorporated into total vasopressor burden. CONCLUSIONS: Greater reductions in vasopressor requirements following angiotensin II initiation were strongly associated with improved survival in bloodstream infection-associated septic shock. This relationship was best characterized as a continuous physiologic gradient, with progressively larger reductions in norepinephrine-equivalent dose associated with lower mortality rather than a discrete threshold effect.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.